The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

Left ventricular ejection fraction (EF) remains the major parameter for diagnosis,
phenoty**, prognosis and treatment decisions in heart failure. The 2016 ESC heart failure …

Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

After the publication of the revised edition, therapeutic drugs described in “Future Treatment”
were approved and important evidence for pharmacologic therapy and nonpharmacologic …

Despite guideline recommendations and available evidence, implementation of treatment in
heart failure (HF) is poor. The majority of patients are not prescribed drugs at target doses …

Secondary prevention through comprehensive cardiac rehabilitation has been recognized
as the most cost-effective intervention to ensure favourable outcomes across a wide …

Self‐care is essential in the long‐term management of chronic heart failure. Heart failure
guidelines stress the importance of patient education on treatment adherence, lifestyle …

Aims The Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
developed the HFA Atlas to provide a contemporary description of heart failure (HF) …

Heart failure with reduced ejection fraction (HFrEF) requires a multimodal treatment with
combination of several drugs as the cornerstone for symptomatic and prognostic …

Novel pharmacologic treatment options reduce mortality and morbidity in a cost‐effective
manner in patients with heart failure (HF). Undisputedly, the effective implementation of …